ストックスクリーナーアプリを入手
10.04
1.86%
-0.19
前日終値:
$10.23
開ける：
$10.17
24時間の取引高:
8,178
Relative Volume:
0.09
時価総額：
$862.71M
収益：
$213.45M
当期純損益:
$-72.46M
株価収益率:
-10.10
EPS:
-0.9936
ネットキャッシュフロー:
$-47.28M
1週間 パフォーマンス:
-3.18%
1か月 パフォーマンス:
+0.70%
6か月 パフォーマンス:
+47.86%
1年 パフォーマンス:
+78.65%
1日の値動き範囲:
$10.04
$10.23
1週間の範囲:
$10.04
$10.62
52週間の値動き範囲:
$3.62
$12.25
Valneva Se Adr Stock (VALN) Company Profile
VALN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VALN
Valneva Se Adr
|
10.04 | 878.40M | 213.45M | -72.46M | -47.28M | -0.9936 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Valneva Se Adr Stock (VALN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-19 | 再開されました | H.C. Wainwright | Buy |
| 2022-08-03 | 開始されました | H.C. Wainwright | Buy |
Valneva Se Adr (VALN) 最新ニュース
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SEVALN - Sahm
Valneva (NASDAQ:VALN) Stock Price Down 4.9%Here's Why - MarketBeat
Valneva–Aktie: Finanzierung gesichert, Erwartungen gesenkt! - Finanztrends
Valneva (NASDAQ:VALN) Shares Gap DownWhat's Next? - MarketBeat
Valneva stock falls after FDA suspension forces guidance cut - Investing.com
VALNEVA Déclaration d’actions et de droits de vote : 30 septembre 2025 - GlobeNewswire Inc.
Valneva (NASDAQ:VALN) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Valneva (NASDAQ:VALN) Shares Gap UpHere's What Happened - MarketBeat
VALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Valneva SE Sponsored ADR (NASDAQ:VALN) Short Interest Update - MarketBeat
Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Valneva (NASDAQ:VALN) Trading 5.6% HigherShould You Buy? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Valneva SE Sponsored ADR (NASDAQ:VALN) Short Interest Down 81.3% in August - Defense World
Valneva SE Sponsored ADR (NASDAQ:VALN) Short Interest Up 64.6% in August - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Louisiana First News
Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Investors to Connect - ACCESS Newswire
Guggenheim lowers Valneva stock price target to $13 on Ixchiq BLA suspension - Investing.com
Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Investors to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Valneva SE (VALN) And Encourages Investors to Reach Out - ACCESS Newswire
Valneva announces U.S. FDA’s decision to suspend license of IXCHIQ - MSN
Valneva selloff on FDA suspension overdone, says H.C. Wainwright - MSN
Valneva SE ADR: Rising -26.86% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com
Valneva price target lowered to $14 from $18 at Jefferies - MSN
HC Wainwright Forecasts Valneva's Q3 Earnings (NASDAQ:VALN) - MarketBeat
Jefferies lowers Valneva stock price target to $14 on FDA suspension - Investing.com
Valneva Se Adr (VALN) 財務データ
収益
当期純利益
現金流量
EPS
1.84%
0.50%
大文字化:
|
ボリューム (24 時間):